Gregory S. Burzynski

发表

Recurrent/Persistent Glioblastoma: Complete Response and 24 Years Disease-free Survival in a 45-Year-Old Female Treated with Antineoplastons (Successful Treatment of Glioblastoma with Antineoplastons)

S. Beenken, S. Burzynski, T. Janicki, 2022, Cancer Studies and Therapeutics.

Comprehensive Genomic Profiling of Recurrent Classic Glioblastoma in a Patient Surviving Eleven Years Following Antineoplaston Therapy

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Newly-Diagnosed Anaplastic Astrocytoma-Final Report (Protocol BT-08)

S. Burzynski, T. Janicki, Ania Marszalek, 2015 .

Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme

S. Burzynski, T. Janicki, S. Brookman, 2014 .

Long-term Survival (>13 Years) in a Child With Recurrent Diffuse Pontine Gliosarcoma: A Case Report

S. Burzynski, T. Janicki, Ania Marszalek, 2014, Journal of pediatric hematology/oncology.

A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2014 .

Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2014 .

Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival

S. Burzynski, T. Janicki, S. Brookman, 2014 .

Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Recurrent Advanced Pancreatic Cancer—A Potential Strategy for Improved Survival

S. Burzynski, T. Janicki, S. Brookman, 2014 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)

S. Burzynski, T. Janicki, Ania Marszalek, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)

S. Burzynski, T. Janicki, Ania Marszalek, 2017 .

A Phase II Study of Antineoplastons A 10 and AS 2-1 in Children with Brain Tumors . Final Report ( Protocol BT10 )

S. Burzynski, T. Janicki, Ania Marszalek, 2017 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2016 .

Complete Response and Long-Term Survival (>20 Years) of a Child with Tectal Glioma: A Case Report

S. Burzynski, T. Janicki, Ania Marszalek, 2015, Pediatric Neurosurgery.

Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 and AS2-1

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2016 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 Injections in Adult Patients With Recurrent Anaplastic Astrocytoma—Final report (Protocol BT-15)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

A Phase II Study of Antineoplastons A 10 and AS 2-1 Injections in Adult Patients With Recurrent Anaplastic Astrocytoma — Final report ( Protocol BT15 )

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

Antineoplastons A10 and AS2-1 in the Treatment of Children with Optic Pathway Glioma: Final Report for Protocol BT-23

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2017 .

Implication of Oxidative Stress-Induced Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegeneration and Cancer 101

G. Aliev, G. Ashraf, R. Cacabelos, 2011 .

A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents

S. Burzynski, S. Brookman, G. Burzynski, 2015 .

Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival

S. Burzynski, T. Janicki, S. Brookman, 2014 .

Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case Report

S. Burzynski, T. Janicki, G. Burzynski, 2015 .

Long-Term Survival (Over 20 Years), Complete Response and Normal Childhood Development in Medulloblastoma Treated with Antineoplastons A10 and AS2-1

S. Burzyński, T. Janicki, G. Burzynski, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22)

S. Burzynski, T. Janicki, S. Brookman, 2014 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (Protocol BT-06), and Review of Recent Trials

S. Burzynski, T. Janicki, Ania Marszalek, 2014 .

The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma

S. Burzynski, T. Janicki, Ania Marszalek, 2014, Child's Nervous System.

A 25-year-female with Diffuse Intrinsic Pontine Glioma Surviving for More than Nine Years Following Treatment with Antineoplastons

S. Beenken, T. Janicki, Gregory S. Burzynski, 2022, International Journal of Clinical Oncology and Cancer Research.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

Comprehensive Genomic Profiling of Recurrent Classic Glioblastoma in a Patient Surviving Eleven Years Following Antineoplaston Therapy

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22)

S. Burzynski, T. Janicki, S. Brookman, 2014 .

Inoperable Optic Pathway Glioma: A Seven-Year-Old Male with >35 Years Overall Survival Following Treatment with Antineoplastons

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2023, European Journal of Clinical Medicine.

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2016 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Newly-Diagnosed Anaplastic Astrocytoma-Final Report (Protocol BT-08)

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2015 .

A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (Protocol BT-06), and Review of Recent Trials

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2014 .

The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma

S. Burzynski, T. Janicki, Gregory S. Burzynski, 2014, Child's Nervous System.